Paper Details

Paper Title

Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast Cancer.

Paper Journal Title

Clin Cancer Res

Paper Citation Count

Paper Publication Year

2020

Bio Mention

Mesh Descriptor

Author Name	Affiliation
Michael S Cuoco	Broad Institute of MIT and Harvard
Samuel S Freeman	Broad Institute of MIT and Harvard
Samuel S Freeman	Broad Institute of MIT and Harvard
Orit Rozenblatt-Rosen	Broad Institute of MIT and Harvard
Vincent A Miller	Foundation Medicine, Inc. Cambridge
Federica Piccioni	Broad Institute of MIT and Harvard
David E Root	Broad Institute of MIT and Harvard
David E Root	Broad Institute of MIT and Harvard
Aviv Regev	Broad Institute of MIT and Harvard
Aviv Regev
Aviv Regev	Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv Regev	Broad Institute of MIT and Harvard
Aviv Regev	Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology
Aviv Regev
Eric P Winer	Dana-Farber Cancer Institute
Eric P Winer	Harvard Medical School
Eric P Winer	Brigham and Women's Hospital
Nancy U Lin	Dana-Farber Cancer Institute
Nancy U Lin	Brigham and Women's Hospital
Nancy U Lin	Harvard Medical School
Nikhil Wagle	Center for Cancer Precision Medicine, Dana-Farber Cancer Institute
Nikhil Wagle	Dana-Farber Cancer Institute
Nikhil Wagle	Harvard Medical School
Nikhil Wagle	Broad Institute of MIT and Harvard
Nikhil Wagle	Brigham and Women's Hospital
Nikhil Wagle	Center for Cancer Precision Medicine, Dana-Farber Cancer Institute
Nikhil Wagle	Dana-Farber Cancer Institute
Nikhil Wagle	Harvard Medical School
Nikhil Wagle	Broad Institute of MIT and Harvard
Nikhil Wagle	Brigham and Women's Hospital

Column Actions